Form 8-K - Current report:
SEC Accession No. 0001558370-20-011468
Filing Date
2020-10-14
Accepted
2020-10-14 16:05:43
Documents
13
Period of Report
2020-10-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ardx-20201009x8k.htm   iXBRL 8-K 33533
2 EX-10.1 ardx-20201009xex10d1.htm EX-10.1 67346
  Complete submission text file 0001558370-20-011468.txt   230580

Data Files

Seq Description Document Type Size
3 EX-101.SCH ardx-20201009.xsd EX-101.SCH 3045
4 EX-101.LAB ardx-20201009_lab.xml EX-101.LAB 15412
5 EX-101.PRE ardx-20201009_pre.xml EX-101.PRE 9971
6 EXTRACTED XBRL INSTANCE DOCUMENT ardx-20201009x8k_htm.xml XML 4661
Mailing Address 34175 ARDENWOOD BLVD. FREMONT CA 94555
Business Address 34175 ARDENWOOD BLVD. FREMONT CA 94555 510-745-7047
ARDELYX, INC. (Filer) CIK: 0001437402 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36485 | Film No.: 201239131
SIC: 2834 Pharmaceutical Preparations